Revista espanola de cardiologia最新文献

{"title":"Utilidad pronóstica de la angina persistente tras revascularización percutánea en el síndrome coronario crónico con angiografía y RMC de estrés alteradas","authors":"Nerea Pérez-Solé ,&nbsp;Elena de Dios ,&nbsp;José V. Monmeneu ,&nbsp;María P. López-Lereu ,&nbsp;José Gavara ,&nbsp;César Ríos-Navarro ,&nbsp;Víctor Marcos-Garces ,&nbsp;Héctor Merenciano ,&nbsp;Clara Bonanad ,&nbsp;Joaquim Cánoves ,&nbsp;Félix Platero ,&nbsp;Andrea Ventura ,&nbsp;David Moratal ,&nbsp;Antoni Bayés-Genís ,&nbsp;Jorge Sanz ,&nbsp;Manuel Jiménez-Navarro ,&nbsp;Luis Martínez-Dolz ,&nbsp;Juan Sanchis ,&nbsp;Julio Núñez ,&nbsp;Vicente Bodí","doi":"10.1016/j.recesp.2024.09.007","DOIUrl":"10.1016/j.recesp.2024.09.007","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>In patients with established chronic coronary syndrome (CCS), the significance of persistent angina is controversial. We aimed to evaluate the prognostic role of persistent angina in symptomatic CCS patients with abnormal stress cardiovascular magnetic resonance (CMR) and altered angiographic findings undergoing percutaneous revascularization.</div></div><div><h3>Methods</h3><div>We analyzed 334 CCS patients with Canadian Cardiovascular Society angina class ≥<!--> <!-->2, perfusion deficits on stress CMR and severe lesions in angiography who underwent medical therapy optimization plus CMR-guided percutaneous revascularization. We investigated the association of persistent angina at 6 months postintervention with subsequent cardiac death, myocardial infarction, and hospital admission.</div></div><div><h3>Results</h3><div>All patients had angina class ≥<!--> <!-->2 (mean: 2.8<!--> <!-->±<!--> <!-->0.7), abnormal stress CMR (mean ischemic burden: 5.8<!--> <!-->±<!--> <!-->2.7 segments), and severe angiographic lesions. The angina resolution rates were 81% at 6 months, and 81%, 81%, and 77% at 1, 2, and 5 years, respectively. During a median follow-up of 8.9 years, persistent angina was independently associated with higher rates of subsequent cardiac death (13% vs 4%; HR, 3.7; 95%<span>C</span>I, 1.5-9.2; <em>P</em> <!-->=<!--> <!-->.005), myocardial infarction (24% vs 6%; HR, 4.9; 95%CI, 2.4–9.9; <em>P</em> <!-->&lt;<!--> <!-->.001), and hospital admission for heart failure (27% vs 13%; HR, 2.7; 95%CI, 1.5–5.2; <em>P</em> <!-->=<!--> <!-->.001).</div></div><div><h3>Conclusions</h3><div>In CCS patients with robust diagnostic evidence from symptoms, stress CMR, and angiography, persistent angina after percutaneous revascularization is a strong predictor of subsequent cardiac death, myocardial infarction, and hospital admission for heart failure.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 5","pages":"Pages 425-436"},"PeriodicalIF":5.9,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143879482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fragilidad y tratamiento invasivo en el SCASEST: luces y sombras","authors":"Francisco Buendía-Santiago,&nbsp;Antonio Meseguer-Hernández,&nbsp;José Manuel Andreu-Cayuelas,&nbsp;Juan Antonio Castillo-Moreno","doi":"10.1016/j.recesp.2024.11.013","DOIUrl":"10.1016/j.recesp.2024.11.013","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 4","pages":"Pages 384-385"},"PeriodicalIF":5.9,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143706156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nueva prótesis percutánea expandible con balón Myval: revisión sistemática de las indicaciones aórtica, mitral, tricuspídea y pulmonar","authors":"Mario García-Gómez ,&nbsp;Clara Fernández-Cordón ,&nbsp;José Carlos González-Gutiérrez ,&nbsp;Ana Serrador ,&nbsp;Alberto Campo ,&nbsp;Carlos Cortés Villar ,&nbsp;Sara Blasco Turrión ,&nbsp;Cristhian Aristizábal ,&nbsp;Julio Peral Oliveira ,&nbsp;Alexander Stepanenko ,&nbsp;Mikel González Arribas ,&nbsp;Luca Scorpiglione ,&nbsp;Akash Jain ,&nbsp;David Carnicero Martínez ,&nbsp;J. Alberto San Román ,&nbsp;Ignacio J. Amat-Santos","doi":"10.1016/j.recesp.2024.09.013","DOIUrl":"10.1016/j.recesp.2024.09.013","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Myval technology represents the first balloon-expandable alternative since the Edwards system became commercially available. Despite certain controversies, its use has rapidly expanded. We aimed to gather all the available literature regarding its indications and outcomes.</div></div><div><h3>Methods</h3><div>A comprehensive search of articles published between December 2016 and May 2024 was conducted using BioMedCentral, Google Scholar, and PubMed to evaluate the main outcomes of Myval for native aortic stenosis (AS) (meta-analysis) and off-label uses (systematic review).</div></div><div><h3>Results</h3><div>A total of 151 studies were identified, and 74 were included in the analysis, covering aortic (n<!--> <!-->=<!--> <!-->51), mitral (n<!--> <!-->=<!--> <!-->9), tricuspid (n<!--> <!-->=<!--> <!-->6), and pulmonary (n<!--> <!-->=<!--> <!-->8) valve positions. A meta-analysis of studies on native AS demonstrated that Myval is safe and effective, with a 30-day mortality rate of 1.3%, good hemodynamic performance, low rates of pacemaker implantation (8.8%), and ≥ moderate paravalvular regurgitation (1.3%). Compared with other contemporary devices, Myval was competitive and associated with lower rates of pacemaker implantation. In a systematic review of off-label indications, Myval was also found to be safe and effective. In bicuspid AS, pure regurgitation, and aortic valve-in-valve procedures, success rates were 100%, 92%, and 100%, respectively, with pacemaker rates of 9.9%, 22.2%, and 3%, respectively. For mitral valve-in-valve/in-ring procedures, the success rate was 96.9%, while in tricuspid and pulmonary positions, small case series reported 100% success rates for both, with minimal procedural complications.</div></div><div><h3>Conclusions</h3><div>Myval technology is safe and effective for the treatment of native valvular disease and dysfunctional prostheses or rings in all heart valve positions, although larger scale studies are warranted.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 5","pages":"Pages 447-464"},"PeriodicalIF":5.9,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143879368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"¿Post operatorio, post-operatorio, postoperatorio, pos operatorio, pos-operatorio o posoperatorio?","authors":"","doi":"10.1016/j.recesp.2024.06.001","DOIUrl":"10.1016/j.recesp.2024.06.001","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 12","pages":"Page 975"},"PeriodicalIF":5.9,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142720606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tormenta eléctrica postural: una rara consecuencia de un rabdomiosarcoma metastásico","authors":"Joana Brito,&nbsp;Tanguy Bois,&nbsp;Raphaël P. Martins","doi":"10.1016/j.recesp.2024.09.012","DOIUrl":"10.1016/j.recesp.2024.09.012","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 4","pages":"Pages 380-381"},"PeriodicalIF":5.9,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143706168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Asociación en J entre la apolipoproteína B y resultados CV en pacientes con síndrome coronario crónico tratados con estatinas","authors":"Jining He ,&nbsp;Zhangyu Lin ,&nbsp;Chenxi Song ,&nbsp;Sheng Yuan ,&nbsp;Xiaohui Bian ,&nbsp;Bowen Li ,&nbsp;Wenjun Ma ,&nbsp;Kefei Dou","doi":"10.1016/j.recesp.2024.08.013","DOIUrl":"10.1016/j.recesp.2024.08.013","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The association between apolipoprotein B (apoB) and residual cardiovascular (CV) risk in patients with chronic coronary syndrome (CCS) remains unclear. We aimed to investigate the association between apoB levels and CV outcomes in statin-treated CCS patients.</div></div><div><h3>Methods</h3><div>We enrolled 8641 statin-treated CCS patients at Fuwai Hospital. The patients were divided into 5 groups based on to apoB quintiles (Q1 to Q5). The primary endpoint was 3-year CV events, including CV death, nonfatal myocardial infarction, and nonfatal stroke.</div></div><div><h3>Results</h3><div>During a median follow-up of 3.17 years, there were 232 (2.7%) CV events. After multivariable adjustment, a restricted cubic spline illustrated a J-shaped relationship between apoB levels and 3-year CV events, with the risk remaining flat until apoB levels exceeded 0.73<!--> <!-->g/L, after which the risk increased (nonlinear <em>P</em> &lt;<!--> <!-->.05). Kaplan-Meier curves showed the lowest CV event rate in the Q3 group (0.68-0.78<!--> <!-->g/L). Compared with the Q3 group, multivariable Cox regression models revealed that both low (Q1, ≤<!--> <!-->0.57<!--> <!-->g/L) and high (Q5, &gt;<!--> <!-->0.93<!--> <!-->g/L) apoB levels were associated with an increased risk of major adverse cardiac events (all <em>P</em> &lt;<!--> <!-->.05). Notably, patients with low apoB levels (Q1) had the highest risk of CV death (HR, 2.44; 95%CI, 1.17-5.08).</div></div><div><h3>Conclusions</h3><div>Our analysis indicates that both low and high levels of apoB are associated with elevated CV risk, with the risk being particularly pronounced at higher levels (&gt; 0.73<!--> <!-->g/L).</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 5","pages":"Pages 404-413"},"PeriodicalIF":5.9,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143879477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implante percutáneo de válvula pulmonar para el tratamiento de la cardiopatía carcinoide","authors":"Gaspard Suc ,&nbsp;Agnes Cachier ,&nbsp;Sebastien Hascoet ,&nbsp;Dimitri Arangalage ,&nbsp;Bernard Iung ,&nbsp;Marina Urena","doi":"10.1016/j.recesp.2024.09.002","DOIUrl":"10.1016/j.recesp.2024.09.002","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 4","pages":"Pages 368-371"},"PeriodicalIF":5.9,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143706164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reingresos recurrentes por insuficiencia cardiaca: una condición persistente pese a alcanzar la estabilidad","authors":"Fernando Aguilar Rodríguez ,&nbsp;Javier de Juan Bagudá ,&nbsp;Rafael Salguero Bodes ,&nbsp;José Luis Bernal Sobrino ,&nbsp;Daniel Ferreiro López ,&nbsp;Juan F. Delgado Jiménez","doi":"10.1016/j.recesp.2024.11.008","DOIUrl":"10.1016/j.recesp.2024.11.008","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 6","pages":"Pages 563-565"},"PeriodicalIF":5.9,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144134578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impacto clínico de la adiposidad visceral en la mortalidad a largo plazo de pacientes sometidos a revascularización coronaria","authors":"Jinhwan Jo ,&nbsp;Seung Hun Lee ,&nbsp;Jeong Hoon Yang ,&nbsp;Sung Mok Kim ,&nbsp;Ki Hong Choi ,&nbsp;Young Bin Song ,&nbsp;Dong Seop Jeong ,&nbsp;Joo Myung Lee ,&nbsp;Taek Kyu Park ,&nbsp;Joo-Yong Hahn ,&nbsp;Seung-Hyuk Choi ,&nbsp;Su Ryeun Chung ,&nbsp;Yang Hyun Cho ,&nbsp;Kiick Sung ,&nbsp;Wook Sung Kim ,&nbsp;Hyeon-Cheol Gwon ,&nbsp;Young Tak Lee","doi":"10.1016/j.recesp.2024.09.004","DOIUrl":"10.1016/j.recesp.2024.09.004","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Although visceral adiposity increases cardiovascular risk in the general population, the obesity paradox has been reported in critically ill patients. However, evidence for its prognostic role in patients undergoing coronary artery bypass grafting (CABG) is limited. This study evaluated the prognostic implications of visceral adiposity in patients who underwent CABG using computed tomography-based measurement of visceral fat.</div></div><div><h3>Methods</h3><div>A total of 2810 patients who underwent CABG from 2007 to 2017 were analyzed. The study population was classified into 3 groups according to visceral fat area index (VFAI) tertiles. VFAI was calculated as visceral fat area (cm²)/height² (m²) at the L3 level. The primary outcome was all-cause mortality during follow-up.</div></div><div><h3>Results</h3><div>Patients in the low VFAI group (lowest tertile) were younger and had a lower body mass index and less subcutaneous fat than those in the high VFAI group (highest tertile). During a median 8.7-year follow-up, VFAI was significantly associated with the risk of mortality in restricted cubic spline curve analysis (HR, 0.94 per 10 increases; 95%<span>C</span>I, 0.91-0.97; <em>P</em> <!-->&lt;<!--> <!-->.001). Patients in the low VFAI group had a higher incidence of long-term mortality than those in the intermediate and high VFAI groups (T1 36.1%, T2 27.2%, and T3 29.1%; T1 vs T2; adjusted HR, 1.36; 95%CI, 1.15-1.61; <em>P</em> <!-->&lt;<!--> <!-->.001; T1 vs T3; adjusted HR, 1.37; 95%CI, 1.16-1.62; <em>P</em> <!-->&lt;<!--> <!-->.001). Similar results were obtained after inverse probability treatment-weighting analysis.</div></div><div><h3>Conclusions</h3><div>Low visceral adiposity was associated with an increased risk of long-term mortality in patients who underwent CABG.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 5","pages":"Pages 437-446"},"PeriodicalIF":5.9,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143879367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Siglas sinónimas y polisémicas","authors":"","doi":"10.1016/j.recesp.2024.11.009","DOIUrl":"10.1016/j.recesp.2024.11.009","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 5","pages":"Pages 387-388"},"PeriodicalIF":5.9,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143879474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}